Complex mixtures of antibodies generated from a single production qualitatively and quantitatively evaluated by native Orbitrap mass spectrometry.
about
Characterization of Pharmaceutical IgG and Biosimilars Using Miniaturized Platforms and LC-MS/MS.Functional assessment of antibody oxidation by native mass spectrometry.Recombinant snakebite antivenoms: A cost-competitive solution to a neglected tropical disease?Structural Characterization of a Thrombin-Aptamer Complex by High Resolution Native Top-Down Mass Spectrometry.Cutting-edge mass spectrometry methods for the multi-level structural characterization of antibody-drug conjugates.Defining the stoichiometry and cargo load of viral and bacterial nanoparticles by Orbitrap mass spectrometryPrecise quantification of mixtures of bispecific IgG produced in single host cells by liquid chromatography-Orbitrap high-resolution mass spectrometry.Rapid characterization of biotherapeutic proteins by size-exclusion chromatography coupled to native mass spectrometryApplication of the Exactive Plus EMR for automated protein-ligand screening by non-covalent mass spectrometry.Quantitation of the Noncovalent Cellular Retinol-Binding Protein, Type 1 Complex Through Native Mass Spectrometry.Native mass spectrometry combined with enzymatic dissection unravels glycoform heterogeneity of biopharmaceuticals.Recent Advances in Next Generation Snakebite AntivenomsDetailed mass analysis of structural heterogeneity in monoclonal antibodies using native mass spectrometry
P2860
Q35975965-C591C0F4-4A6B-4761-96DE-89FE0650D53CQ36213342-14D2971E-1245-4C0E-A713-9D1E4B9E7B66Q36269593-730F5DEA-A554-4147-BF66-592B785C46CCQ38287623-75A36BFE-E575-4990-ABB2-7B4CB0CA2E63Q38665164-EDD147B5-073A-4539-951E-CBBF39ED7E53Q40351302-110400B2-AF36-461A-B431-FDBB8F66570BQ41899683-CE06C188-33C6-428A-8711-5491E1A4DC20Q41901269-95C71075-BBE1-4E76-ACAC-FBFEA348DDC6Q44432930-FBD19CF4-4B3B-4BBE-9028-6E425F7F3C2FQ47149969-13177B66-23A3-4E27-B33F-08D3E6C7EE75Q55009874-595DF47E-DEE7-4EE4-A12A-B5730A1C92AFQ56889475-69FC7F5B-4B05-4FF3-BDBB-5ABF4849EA3AQ57666042-024F1811-89D6-4AE3-9CCA-3825DEC7FF4F
P2860
Complex mixtures of antibodies generated from a single production qualitatively and quantitatively evaluated by native Orbitrap mass spectrometry.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Complex mixtures of antibodies ...... ve Orbitrap mass spectrometry.
@en
Complex mixtures of antibodies ...... ve Orbitrap mass spectrometry.
@nl
type
label
Complex mixtures of antibodies ...... ve Orbitrap mass spectrometry.
@en
Complex mixtures of antibodies ...... ve Orbitrap mass spectrometry.
@nl
prefLabel
Complex mixtures of antibodies ...... ve Orbitrap mass spectrometry.
@en
Complex mixtures of antibodies ...... ve Orbitrap mass spectrometry.
@nl
P2093
P2860
P356
P1476
Complex mixtures of antibodies ...... ve Orbitrap mass spectrometry.
@en
P2093
John de Kruif
Linda J A Hendriks
Mark Throsby
Natalie J Thompson
P2860
P304
P356
10.4161/MABS.27126
P577
2014-01-01T00:00:00Z